Aprea Therapeutics logo

Aprea Therapeutics share price today

(APRE)

Aprea Therapeutics share price is $3.14 & ₹267.52 as on 25 Dec 2024, 2.30 'hrs' IST

$3.14

0.24

(8.28%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Aprea Therapeutics share price in Dollar and Rupees. Guide to invest in Aprea Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Aprea Therapeutics. Get details on the Indian mutual funds that are investing in Aprea Therapeutics. Get Analyst recommendations and forecasts along with all the Aprea Therapeutics's financials.

Aprea Therapeutics share price movements

  • Today's Low: $3.07
    Today's High: $3.17

    Day's Volatility :3.02%

  • 52 Weeks Low: $2.15
    52 Weeks High: $8.85

    52 Weeks Volatility :75.7%

Aprea Therapeutics Returns

PeriodAprea Therapeutics IncIndex (Russel 2000)
3 Months
7.53%
0.0%
6 Months
-23.23%
0.0%
1 Year
-15.14%
0.0%
3 Years
-95.11%
-21.1%

Aprea Therapeutics Key Statistics

in dollars & INR

Previous Close
$2.9
Open
$3.09
Today's High
$3.1656
Today's Low
$3.07
Market Capitalization
$15.8M
Today's Volume
$11.2K
52 Week High
$8.8465
52 Week Low
$2.1501
Revenue TTM
$1.3M
EBITDA
$-14.2M
Earnings Per Share (EPS)
$-2.8
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-50.11%

How to invest in Aprea Therapeutics from India?

It is very easy for Indian residents to invest directly in Aprea Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Aprea Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Aprea Therapeutics or APRE on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Aprea Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Aprea Therapeutics shares which would translate to 0.271 fractional shares of Aprea Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Aprea Therapeutics, in just a few clicks!

Returns in Aprea Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Aprea Therapeutics investment value today

Current value as on today

₹87,291

Returns

₹12,709

(-12.71%)

Returns from Aprea Therapeutics Stock

₹15,135 (-15.14%)

Dollar Returns

₹2,426 (+2.43%)

Indian investors sentiment towards Aprea Therapeutics

46%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Aprea Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 46% more investors are searching Aprea Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Aprea Therapeutics

  • AIGH Capital Management, LLC

    9.92%

  • Sio Capital Management, LLC

    5.09%

  • Sphera Funds Management Ltd.

    4.97%

  • Nantahala Capital Management, LLC

    3.79%

  • Vanguard Group Inc

    3.20%

  • Dafna Capital Management LLC

    2.52%

Analyst Recommendation on Aprea Therapeutics

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Aprea Therapeutics(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Aprea Therapeutics

What analysts predicted

Upside of 398.94%

Current:

$3.14

Target:

$15.67

Insights on Aprea Therapeutics

  • Price Movement

    In the last 3 years, APRE stock has moved down by -95.3%
  • APRE vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.3% return, outperforming this stock by 43.3%
  • APRE vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 120.5%
  • Price to Sales

    ForAPRE every $1 of sales, investors are willing to pay $10.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Aprea Therapeutics Technicals Summary

Sell

Neutral

Buy

Aprea Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Aprea Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Aprea Therapeutics Inc
7.9%
-23.23%
-15.14%
-95.11%
-99.67%
Regeneron Pharmaceuticals, Inc.
-4.68%
-32.01%
-18.29%
12.56%
91.19%
Biontech Se
-5.49%
41.99%
6.11%
-55.22%
226.93%
Alnylam Pharmaceuticals, Inc.
-3.08%
-1.52%
23.75%
50.98%
112.09%
Vertex Pharmaceuticals Incorporated
-11.59%
-13.61%
0.03%
83.58%
86.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Aprea Therapeutics Inc
0.48
NA
NA
-2.41
-0.5
-0.3
NA
4.54
Regeneron Pharmaceuticals, Inc.
17.7
17.7
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Aprea Therapeutics Inc
Buy
$15.8M
-99.67%
0.48
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.6B
91.19%
17.7
33.61%
Biontech Se
Buy
$27.2B
226.93%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.2B
112.09%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$104.4B
86.41%
32.84
-4.51%

About Aprea Therapeutics

annan naturvetenskaplig och teknisk forskning och utveckling
Organization
Aprea Therapeutics
Employees
7
CEO
Dr. Oren Gilad Ph.D.
Industry
Commercial Services

Management People of Aprea Therapeutics

NameTitle
Dr. Oren Gilad Ph.D.
Co-Founder, CEO, President & Director
Mr. John P. Hamill CPA
Senior VP, CFO, Principal Accounting Officer & Secretary
Dr. Dansu Li Ph.D.
Head of Technology
Dr. Lars B. Abrahmsen Ph.D.
Senior VP & Chief Scientific Officer
Mr. Brian Wiley
Senior Vice President of Corporate Development & Strategy
Dr. Michel Afargan Ph.D.
Head of Pharmacology Development
Mr. Ze'ev Weiss B.Sc., C.P.A.
Chief Business Advisor
Dr. Nadeem Q. Mirza M.D., M.P.H.
Executive Officer
Ms. Andrea Epstein
Controller

Important FAQs about investing in Aprea Therapeutics from India :

What is Aprea Therapeutics share price today?

Aprea Therapeutics share price today stands at $3.14, Open: $3.09 ; Previous Close: $2.90 ; High: $3.17 ; Low: $3.07 ; 52 Week High: $8.85 ; 52 Week Low: $2.15. The stock opens at $3.09, after a previous close of $2.90. The stock reached a daily high of $3.17 and a low of $3.07, with a 52-week high of $8.85 and a 52-week low of $2.15.

Can Indians buy Aprea Therapeutics shares?

Yes, Indians can invest in the Aprea Therapeutics (APRE) from India.

With INDmoney, you can buy Aprea Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Aprea Therapeutics at zero transaction cost.

How can I buy Aprea Therapeutics shares from India?

It is very easy to buy Aprea Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Aprea Therapeutics be purchased?

Yes, you can buy fractional shares of Aprea Therapeutics with INDmoney app.

What are the documents required to start investing in Aprea Therapeutics stocks?

To start investing in Aprea Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Aprea Therapeutics

Today’s highest price of Aprea Therapeutics (APRE) is $3.17.

Today’s lowest price of Aprea Therapeutics (APRE) is $3.07.

What is today's market capitalisation of Aprea Therapeutics

Today's market capitalisation of Aprea Therapeutics APRE is 15.8M

What is the 52 Week High and Low Range of Aprea Therapeutics

  • 52 Week High

    $8.85

  • 52 Week Low

    $2.15

What are the historical returns of Aprea Therapeutics?

  • 1 Month Returns

    7.9%

  • 3 Months Returns

    -23.23%

  • 1 Year Returns

    -15.14%

  • 5 Years Returns

    -99.67%

Who is the Chief Executive Officer (CEO) of Aprea Therapeutics

Dr. Oren Gilad Ph.D. is the current Chief Executive Officer (CEO) of Aprea Therapeutics.